Search

Your search keyword '"Goss JA"' showing total 328 results

Search Constraints

Start Over You searched for: Author "Goss JA" Remove constraint Author: "Goss JA"
328 results on '"Goss JA"'

Search Results

2. Somatic mutations in intracranial arteriovenous malformations

3. Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial

8. The impact of recipient hypernatremia on pediatric liver transplantation outcomes.

9. A 10-year analysis of the racial distribution of authors in plastic surgery research and the impact of minority mentorship.

10. Incidence and risk factors for chronic rejection in pediatric liver transplantation.

11. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America.

12. Severe febrile neutropenia and pancytopenia in a patient with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: a case report.

13. A Surgical Collaborative to Empower Medical Student Research.

14. Estimating risk of prolonged mechanical ventilation after liver transplantation in children: PROVE-ALT score.

15. Retrospective Analysis of the Impact of High- and Low-Quality Donor Livers for Patients with High-Acuity Illness.

16. Papillary Hemangioma Harbors Somatic GNA11 and GNAQ Mutations.

17. The Multidisciplinary Pediatric Liver Transplant.

18. Critical elements of pediatric liver cancer surgery.

19. Surgical Management and Outcomes of Patients with Multifocal Hepatoblastoma.

20. Survival Benefit of Solid-Organ Transplantation: 10-Year Update.

21. Radiological-histopathological discordance in patients transplanted for HCC and its impact on post-transplant outcomes.

23. Selecting DCD Recipients Using Predictive Indices.

24. Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras.

25. Cartilage-inspired surface textures for improved tribological performance of orthopedic implants.

26. Acute liver failure and unique challenges of pediatric liver transplantation amidst a worldwide cluster of adenovirus-associated hepatitis.

27. Long-term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States.

28. Innate immune cell dysfunction and systemic inflammation in children with chronic liver diseases undergoing transplantation.

29. A new chapter in an evolving pandemic: Successful pediatric liver transplantation with SARS-CoV-2+ donors.

31. Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.

32. Recipient Age Predicts 20-Year Survival in Pediatric Liver Transplant.

33. Our evolution in the treatment of hepatic artery and portal vein thrombosis in pediatric liver transplantation: Success with catheter-directed therapies.

34. Trends in marginal lung allograft survival: Advanced-age donors improve.

35. Integration of a dedicated management protocol in the care of pediatric liver cancer: From specialized providers to complication reduction.

36. Do Patients with Autoimmune Conditions Have Less Access to Liver Transplantation despite Superior Outcomes?

37. Significant improvements, but consistent disparities in survival for African Americans after liver transplantation.

38. The impact of diabetes on young transplant recipients: An American perspective.

39. Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma.

40. Marginal allografts in liver transplantation have a limited impact on length of stay.

41. Trends in Survival for Pediatric Transplantation.

43. COVID-19 Vaccine Efficacy and Immunogenicity in End-Stage Renal Disease Patients and Kidney Transplant Recipients.

45. Allograft discard risk index for lung transplantation.

46. Allograft discard risk index for heart transplantation.

47. Transarterial Radioembolization Treatment as a Bridge to Surgical Resection in Pediatric Hepatocellular Carcinoma.

48. The Surge in Deceased Liver Donors Due to the Opioid Epidemic: Is It Time to Split the Difference?

49. Management of Acute Portal Vein Thrombosis With Serial Mechanical Thrombectomy and tPA in a Pediatric Liver Transplant Recipient: A Case Report.

50. Intent-to-treat survival in liver transplantation has not improved in 3 decades due to donor shortage relative to waitlist growth.

Catalog

Books, media, physical & digital resources